Three products. One governed clinical AI stack.
Privexa Trace governs reviewer-gated synthetic control arm workflows. Privexa protects clinical data before it reaches any AI system. The diagnostic pipeline extends Translyx's reach across AMR, sepsis, POCT, and precision medicine.
Portfolio overview
Translyx is the company. Privexa and Privexa Trace solve different parts of the operating model.
Flagship product
AvailablePrivexa Trace
Reviewer-gated synthetic control arm workflows with manual benchmark comparison, lineage, visible limitations, and submission-oriented packaging.
Protection layer
AvailablePrivexa
Enterprise AI privacy platform. Five protection layers — Secure LLM Gateway, Cloud Shield, Privexa Scribe, Document Intelligence, and Governance. Live at app.privexa.co.
Broader portfolio
PipelineClinical & Diagnostic Pipeline
AMR, sepsis diagnostics, point-of-care testing, endocrinology, cardiac markers, and precision medicine products for New Zealand healthcare.
Product architecture
One company. Two products. One clinical mission.
Parent company
Translyx Limited
Clinical technology holding entity · Auckland, New Zealand
Protection layer
Privexa
Field-level AI data protection for healthcare workflows. Sensitive data never leaves your environment.
Flagship product
Privexa Trace
Reviewer-gated synthetic control arm workflows with lineage, manual benchmark comparison, and submission-oriented packaging.
Broader portfolio
Clinical & Diagnostic Pipeline
AMR, sepsis diagnostics, point-of-care testing, endocrinology, cardiac markers, and precision medicine products for New Zealand healthcare.
View pipelineSpeak with Translyx about your clinical AI priorities
Request a walkthrough to see Privexa Trace's synthetic control workflow, Privexa's data protection architecture, and the broader Translyx diagnostic portfolio in context.